Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katalin Danko

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Best Practice & Research. Clinical Rheumatology|March 20, 2012
Idiopathic inflammatory myopathiesMelinda Vincze, Katalin Danko
Clinical Rheumatology|July 2, 2008
Rare association of antisynthetase syndrome and Kennedy's diseaseNora Szabo, Szilveszter Lukacs, Wiranthi Gunasekera, et al.
Rheumatology (Oxford, England)|November 16, 2019
Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositisZoe Betteridge, Hector Chinoy, Jiri Vencovsky, et al.
Ocular Immunology and Inflammation|November 17, 2018
Corneal Involvement of Patients with Polymyositis and DermatomyositisZoltan Griger, Katalin Danko, Levente Bodoki, et al.
Rheumatology (Oxford, England)|July 2, 2010
Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligandPeter Szodoray, Philip Alex, Nicholas Knowlton, et al.
International Journal of Ophthalmology|September 21, 2020
Anterior segment parameters associated with extramuscular manifestations in polymyositis and dermatomyositisZoltan Griger, Katalin Danko, Gabor Nemeth, et al.
Annals of the New York Academy of Sciences|September 6, 2007
Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseasesHedi Orbach, Gisele Zandman-Goddard, Howard Amital, et al.
Clinical Rheumatology|November 8, 2011
A novel automated indirect immunofluorescence autoantibody evaluationShaye Kivity, Boris Gilburd, Nancy Agmon-Levin, et al.
Rheumatology (Oxford, England)|November 30, 2014
Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroidsFowzia Ibrahim, Ernest Choy, Patrick Gordon, et al.
Arthritis and Rheumatism|August 29, 2013
Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disordersFrederick W Miller, Robert G Cooper, Jiří Vencovský, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Best Practice & Research. Clinical Rheumatology|March 20, 2012
Idiopathic inflammatory myopathiesMelinda Vincze, Katalin Danko
Clinical Rheumatology|July 2, 2008
Rare association of antisynthetase syndrome and Kennedy's diseaseNora Szabo, Szilveszter Lukacs, Wiranthi Gunasekera, et al.
Rheumatology (Oxford, England)|November 16, 2019
Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositisZoe Betteridge, Hector Chinoy, Jiri Vencovsky, et al.
Ocular Immunology and Inflammation|November 17, 2018
Corneal Involvement of Patients with Polymyositis and DermatomyositisZoltan Griger, Katalin Danko, Levente Bodoki, et al.
Rheumatology (Oxford, England)|July 2, 2010
Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligandPeter Szodoray, Philip Alex, Nicholas Knowlton, et al.
International Journal of Ophthalmology|September 21, 2020
Anterior segment parameters associated with extramuscular manifestations in polymyositis and dermatomyositisZoltan Griger, Katalin Danko, Gabor Nemeth, et al.
Annals of the New York Academy of Sciences|September 6, 2007
Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseasesHedi Orbach, Gisele Zandman-Goddard, Howard Amital, et al.
Clinical Rheumatology|November 8, 2011
A novel automated indirect immunofluorescence autoantibody evaluationShaye Kivity, Boris Gilburd, Nancy Agmon-Levin, et al.
Rheumatology (Oxford, England)|November 30, 2014
Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroidsFowzia Ibrahim, Ernest Choy, Patrick Gordon, et al.
Arthritis and Rheumatism|August 29, 2013
Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disordersFrederick W Miller, Robert G Cooper, Jiří Vencovský, et al.
Pageof 2